These results indicated that N-glycosylation of FCN3 at Asn189 facilitated Wnt/β-catenin signaling activation, β‐catenin nuclear translocation and Treg cell activation, thereby promoting HCC progression. The gene discussed is FCN3; the disease is hepatocellular carcinoma.